Abstract
Juvenile systemic lupus erythematosus is a rare multisystemic autoimmune disease with variable clinical manifestations, and disease onset before 16 years of age. Patients younger than 5 years are rarely affected and the age of onset may contribute to the course of disease in terms of clinical presentation, organ involvement, and serological findings. Here, we report two exemplary early-onset SLE patients, a 28-month-old patient with WHO class IIB kidney disease, arthritis, and a typical antibody constellation and an 11-month-old infant that presented with microcytic anemia, leukocytosis, arthritis, fasciitis, fatty liver disease, protein losing enteropathy, edema, and minimal change glomerulonephritis. Epidemiologic and clinical features of early-onset SLE compared to other forms of SLE are given and differential diagnoses and treatment options are discussed.
Similar content being viewed by others
References
Zulian F, Pluchinotta F, Martini G, Da Dalt L, Zacchello G (2008) Severe clinical course of systemic lupus erythematosus in the first year of life. Lupus 17(9):780–786
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
Jordan SC, Lemire JM, Border W, Sakai R, Ettenger RB, Fine RN (1984) False-negative anti-DNA antibody activity in infantile systemic lupus erythematosus (SLE). Clin Immunol 4(2):156–162
Anderson JR (1981) Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations. Neuropathol Appl Neurobiol 7(2):161–166
Cummings NP, Hansen J, Hollister JR (1985) Systemic lupus erythematosus in a premature infant. Arthritis Rheum 28(5):573–575
Pope JE (2002) Scleroderma overlap syndromes. Curr Opin Rheumatol 14(6):704–710
Horn HC, Ottosen P, Junker P (2001) Renal crisis in asclerodermic scleroderma–lupus overlap syndrome. Lupus 10(12):886–888
Cassidy JT, Petty RE, Laxer RM, Lindsley CB (2005) Textbook of pediatric rheumatology 5th edn. Elsevier, Amsterdam, pp 342–391
Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, Heubner G, Lee-Kirsch MA, Gahr M (2008) Chilblain lupus erythematosus—a review of literature. Clin Rheumatol 27(8):949–954, Epub 2008 Jun 10
Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschênes G, Koné-Paut I, Leblanc T, Loirat C, Niaudet P, Piette JC, Prieur AM, Quartier P, Bouissou F, Foulard M, Leverger G, Lemelle I, Pilet P, Rodière M, Sirvent N, Cochat P (2005) Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146(5):648–653
Heidet L, Gubler MC (2009) The renal lesions of Alport syndrome. J Am Soc Nephrol 20(6):1210–1215, Epub 2009 May 21
Maxon WT (1963) Benign proteinuria of childhood and adoslescence: a survey. Clin Pediatr (Phila) 2:662–668
Abaterusso C, De Biase V, Salviati A, Fabris A, Millardi D, Tomei P, Bernich P, Lupo A, Gambaro G (2009) Unusual renal presentation of Fabry disease in a female patient. Nat Rev Nephrol 5(6):349–354, Epub 2009 Apr 28
Strippoli GF, Di Paolo S, Cincione R, Di Palma AM, Teutonico A, Grandaliano G, Schena FP, Gesualdo L (2003) Clinical and therapeutic aspects of diabetic nephropathy. J Nephrol 16(4):487–499
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP (1994) Proteinuria and hypertension. Kidney Int Suppl 47:S76–S80
Tsimihodimos V, Psychogios N, Kakaidi V, Bairaktari E, Elisaf M (2007) Salicylate-induced proximal tubular dysfunction. Am J Kidney Dis 50(3):463–467
John R, Herzenberg AM (2009) Renal toxicity of therapeutic drugs. J Clin Pathol 62(6):505–515
Gibson T, Myers AR (1981) Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 8(5):752–759
Matsumoto T, Yoshimine T, Shimouchi K, Shiotu H, Kuwabara N, Fukuda Y, Hoshi T (1992) The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol 23(10):1151–1158
Jaeken J, Matthijs G (2007) Congenital disorders of glycosylation: a rapidly expanding disease family. Annu Rev Genomics Hum Genet 8:261–278
Lee WM, Seremba E (2008) Etiologies of acute liver failure. Curr Opin Crit Care 14(2):198–201
Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarasamy N (1978) Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta 33(6):465–487
Locher S (1987) Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance. Anasth Intensivther Notfallmed 22(4):194–197
Risser A, Donovan D, Heintzman J, Page T (2009) NSAID prescribing precautions. Am Fam Phys 80(12):1371–1378
Pérez-Gutthann S, García-Rodríguez LA, Duque-Oliart A, Varas-Lorenzo C (1999) Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy 19(7):854–859
Yoshida M, Miyata M, Saka M, Sasajima T, Sato H, Takiguchi J, Shishido H, Saito A, Kokubun M, Nishimaki T, Kasukawa R (2001) Protein-losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus. Intern Med 40(5):449–453
Trentham DE, Masi AT (1976) Systemic lupus erythematosus with a protein-losing enteropathy. JAMA 236(3):287–288
Viallard JF, Fach J, Mercie P, Leng B, Pellegrin JL, Longy-Boursier M (1998) Exudative enteropathy in disseminated lupus erythematosus. Report of 3 cases and review of the literature. Ann Med Interne (Paris) 149(8):485–491
Benner KG, Montanaro A (1989) Protein-losing enteropathy in systemic lupus erythematosus. Diagnosis and monitoring immunosuppressive therapy by alpha-1-antitrypsin clearance in stool. Dig Dis Sci 34(1):132–135
Mader R, Adawi M, Schonfeld S (1997) Malabsorption in systemic lupus erythematosus. Clin Exp Rheumatol 15(6):659–661
Grossman J, Schwartz RH, Callerame ML, Condemi JJ (1975) Systemic lupus erythematosus in a 1-year-old child. Am J Dis Child 129(1):123–125
Dudley J, Fenton T, Unsworth J, Chambers T, MacIver A, Tizard J (1996) Systemic lupus erythematosus presenting as congenital nephrotic syndrome. J Pediatr Nephrol 10(6):752–755
Shetty VB, Rao S, Krishnamurthy PN, Shenoy VU (2001) Peripheral gangrene during infancy: a rare presentation of systemic lupus erythematosus. Arch Dis Child 85(4):335–336
Kreindler J, Ellis D, Vats A, Kurland G, Ranganathan S, Moritz ML (2005) Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage. Pediatr Nephrol 20(4):522–525
Duzova A, Bakkaloglu A (2008) Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment. Curr Pharm Des 14(13):1295–1301
Hedrich CM, Fiebig B, Sallmann S, Bruck N, Hahn G, Roesler J, Roesen-Wolff A, Heubner G, Gahr M (2008) Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies. Scand J Rheumatol 37(5):385–389
Jordan JM, Valenstein P, Kredich DW (1989) Systemic lupus erythematosus with Libman-Sachs endocarditis in a 9-month-old infant with neonatal lupus erythematosus and congenital heart block. Pediatrics 84(3):574–578
Massengill SF, Richard GA, Donnelly WH (1994) Infantile systemic lupus erythematosus with onset simulating congenital nephrotic syndrome. J Pediatr 124(1):27–31
Saberi MS, Jones BA (1998) Remission of infantile systemic lupus erythematosus with intravenous cyclophosphamide. Pediatr Nephrol 12(2):136–138
Gaubitz M, Schotte H (2005) Early diagnosis in patients with systemic lupus erythematosus (SLE). Z Rheumatol 64(8):547–552
Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46(8):2121–2131
Houssiau FA, D’Cruz DP, Sangle SR, Remy P, Vasconcelos C, de Ramon Garrido E, Gilboe IM Sr, Ravelingien I, Tektonidou M, Depresseux G, Guillevin LP, Cervera R (2009) Azathioprine versus mycophenolate mofetil for maintenance immunosuppression of proliferative lupus nephritis: results of a randomized trial (MAINTAIN). Arthritis Rheum 60(10):S429–S430
Silverman E (1996) What’s new in the treatment of pediatric SLE. J Rheumatol 23(9):1657–1660
Austin HA, Balow JE (2000) Treatment of lupus nephritis. Semin Nephrol 20(3):265–276
Valesini G, Priori R, Francia A, Balestrieri G, Tincani A, Airo P, Cattaneo R, Zambruni A, Troianello B, Chofflon M et al (1994) Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol 16(2–3):313–321
Acknowledgments
The authors thank PD Dr. med. D. Aust, Department of Pathology, University Medical Center Carl Gustav Carus, TU Dresden, Germany, for providing us with high quality pictures for this manuscript. We thank Dr. med. Karsten Conrad, Department of Immunology, University Medical Center Carl Gustav Carus, TU Dresden, Germany, for helpful discussion and thoughtful suggestions on differential diagnoses.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hedrich, C.M., Zappel, H., Straub, S. et al. Early onset systemic lupus erythematosus: differential diagnoses, clinical presentation, and treatment options. Clin Rheumatol 30, 275–283 (2011). https://doi.org/10.1007/s10067-010-1576-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1576-2